AMENDED AND RESTATED RESEARCH COLLABORATION AND LICENSE AGREEMENT by and between gilead sciences, Inc. and hookipa biotech gmbHResearch Collaboration and License Agreement • March 1st, 2022 • HOOKIPA Pharma Inc. • Pharmaceutical preparations • New York
This AMENDED AND RESTATED RESEARCH COLLABORATION AND LICENSE AGREEMENT (this “Agreement”) is made as of February 15, 2022 (the “Effective Date”), by and between Gilead Sciences, Inc., a Delaware corporation having an office at 333 Lakeside Drive, Foster City, CA 94404, USA (“Gilead”) and Hookipa Biotech GmbH, an Austrian corporation having an office at St Marx Vienna BioCenter: Helmut-Qualtinger-Gasse 2, 1030 Vienna, Austria (“Hookipa”). Gilead and Hookipa are each referred to individually as a “Party” and together as the “Parties.”
